SCHEMBL25826660

SCHEMBL25826660

N#Cc1ccc2nccc(Nc3cccc(C(=O)Nc4cccc(Nc5ccncc5)c4F)c3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 5/20 0.53
DNMT3A Q9Y6K1 5/20 0.53
USP2 O75604 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
GAK O14976 1/20 0.43
RIPK2 O43353 1/20 0.43
COQ8A Q8NI60 1/20 0.43
NLK Q9UBE8 1/20 0.43
BRAF P15056 2/20 0.43
DNMT3L Q9UJW3 3/20 0.43
EHMT1 Q9H9B1 2/20 0.43
MAPKAPK2 P49137 2/20 0.42
CLK1 P49759 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820634 0.95 DNMT1 (0.57) DNMT1DNMT3AKMT2AGAKRIPK2
SCHEMBL24003759 0.93 DNMT1 (0.55) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL25826556 0.90 DNMT1 (0.54) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL24006012 0.90 DNMT1 (0.54) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL25487276 0.90 DNMT1 (0.53) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL25487871 0.89 DNMT1 (0.59) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL30290822 0.89 DNMT1 (0.59) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL24003769 0.89 DNMT1 (0.65) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL31395379 0.89 DNMT1 (0.65) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL30287672 0.89 DNMT1 (0.65) DNMT1DNMT3AUSP2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885USP2 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.